The differential response to parenteral chlorpromazine and mesoridazine in psychotic patients.
D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002389:Catatonia / Q000188:drug therapy; D002746:Chlorpromazine / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy; D010259:Paranoid Disorders / Q000188:drug therapy; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy
D010640:Phenothiazines; D002746:Chlorpromazine